E

EyeMacular Regeneration, Inc.

“Developing specialized surgical instruments and platform technologies for end-stage macular disease.”

HealthtechSeedRaising $2.0M

Open round — EyeMacular Regeneration, Inc. is raising $2.0M for its Seed

The founder is taking investor conversations now, and on PitchSpark you reach them directly — no warm intro, no gatekeeper.

02

Overview

EyeMacular Regeneration is a medical technology company developing specialized surgical instruments and platform technologies for patients with end-stage macular disease. The company focuses on a novel field called Incisional Choroidal Surgery (ICS) to address severe vision impairments.

03

Traction

as reported by the founder
What problem are you solving?

Patients with end-stage age-related macular degeneration (AMD) often exhaust all existing treatment options, leaving them with limited solutions for their condition.

What makes your product special?

The company has developed innovative, practical surgical instruments and platform technologies designed to integrate seamlessly into existing vitreoretinal surgical workflows.

10

Company updates

No updates posted yet.

Follow this company

Get an email when EyeMacular Regeneration, Inc. posts an update. No account needed — one click to unsubscribe.

11

Achievements

EyeMacular Regeneration, Inc. — raising $2.0M